Gene · 1445
Papers4,278
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
321 to 340 of 4,278
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Spontaneous Osteoclastogenesis, a risk factor for bone metastasis in advanced luminal A-type breast cancer patients. | Front Oncol | 2023 | 36890825 | PubTator, text mining | PubMed |
| OTTERS: a powerful TWAS framework leveraging summary-level reference data. | Nat Commun | 2023 | 36882394 | PubTator, text mining | PubMed |
| Current advances in understanding the molecular profile of hereditary diffuse gastric cancer and its clinical implications. | J Exp Clin Cancer Res | 2023 | 36869400 | PubTator, text mining | PubMed |
| CDCP1 (CUB domain containing protein 1) is a potential urine-based biomarker in the diagnosis of low-grade urothelial carcinoma. | PLoS One | 2023 | 36862682 | PubTator, text mining | PubMed |
| Biochemical Studies of Systemic Lupus Erythematosus-Associated Mutations in Nonreceptor Tyrosine Kinases Ack1 and Brk. | Biochemistry | 2023 | 36854171 | PubTator, text mining | PubMed |
| The short-chain fatty acid butyrate exerts a specific effect on VE-cadherin phosphorylation and alters the integrity of aortic endothelial cells. | Front Cell Dev Biol | 2023 | 36846596 | PubTator, text mining | PubMed |
| PTCL, NOS: An update on classification, risk-stratification, and treatment. | Front Oncol | 2023 | 36845711 | PubTator, text mining | PubMed |
| Genome-Wide Gene-Set Analysis Identifies Molecular Mechanisms Associated with ALS. | Int J Mol Sci | 2023 | 36835433 | PubTator, text mining | PubMed |
| Effect of the Rho-Kinase/ROCK Signaling Pathway on Cytoskeleton Components. | Genes (Basel) | 2023 | 36833199 | PubTator, text mining | PubMed |
| Carbonic Anhydrase II Activators in Osteopetrosis Treatment: A Review. | Curr Issues Mol Biol | 2023 | 36826034 | PubTator, text mining | PubMed |
| Celiac disease-associated loci show considerable genetic overlap with neuropsychiatric diseases but with limited transethnic applicability. | J Genet | 2023 | 36814110 | PubTator, text mining | PubMed |
| Hypertension as a Novel Link for Shared Heritability in Age at Menarche and Cardiometabolic Traits. | J Clin Endocrinol Metab | 2023 | 36810613 | PubTator, text mining | PubMed |
| Analysis of genetically determined gene expression suggests role of inflammatory processes in exfoliation syndrome. | BMC Genomics | 2023 | 36797672 | PubTator, text mining | PubMed |
| Preclinical characterization of pirtobrutinib, a highly selective, noncovalent (reversible) BTK inhibitor. | Blood | 2023 | 36796019 | PubTator, text mining | PubMed |
| Coordinated activation of c-Src and FOXM1 drives tumor cell proliferation and breast cancer progression. | J Clin Invest | 2023 | 36795481 | PubTator, text mining | PubMed |
| Identification of target proteins for breast cancer genetic risk loci and blood risk biomarkers in a large study by integrating genomic and proteomic data. | Int J Cancer | 2023 | 36779764 | PubTator, text mining | PubMed |
| The ectonucleotidases CD39 and CD73 on T cells: The new pillar of hematological malignancy. | Front Immunol | 2023 | 36776866 | PubTator, text mining | PubMed |
| Genetic Background and Molecular Mechanisms of Juvenile Idiopathic Arthritis. | Int J Mol Sci | 2023 | 36768167 | PubTator, text mining | PubMed |
| Exploiting the Stemness and Chemoresistance Transcriptome of Ewing Sarcoma to Identify Candidate Therapeutic Targets and Drug-Repurposing Candidates. | Cancers (Basel) | 2023 | 36765727 | PubTator, text mining | PubMed |
| A reversible SRC-relayed COX2 inflammatory program drives resistance to BRAF and EGFR inhibition in BRAFV600E colorectal tumors. | Nat Cancer | 2023 | 36759733 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/1445/papers?page=17